𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epithelial Membrane Protein 1 Inhibits Human Spinal Chondrocyte Differentiation

✍ Scribed by Zhi-Yong Li; Shao-Hu Xiong; Ming Hu; Chuan-Sen Zhang


Book ID
102745256
Publisher
Wiley (John Wiley & Sons)
Year
2011
Tongue
English
Weight
786 KB
Volume
294
Category
Article
ISSN
1932-8486

No coin nor oath required. For personal study only.

✦ Synopsis


The molecular mechanisms underlying human spinal chondrocyte differentiation remain unclear. We recently demonstrated that epithelial membrane protein 1 (EMP1) is highly expressed in degenerative intervertebral discs. EMP1 is involved in the differentiation of multiple cell types, including progenitor/pre-B cells, neurons, and podocytes. Therefore, we hypothesize that EMP1 may participate in the differentiation of spinal chondrocytes. We cultured chondrocytes from human nucleus pulposus. Through lentivirus-mediated knockdown and overexpression of EMP1, we find that EMP1 promotes cell proliferation and survival, alters cell morphology and cell cycle, reduces cell condensation, and inhibits cell hypertrophy and the expression of chondrocyte maturation markers such as collagen X, aggrecan, sex-determining region Y (SRY)-box 9, and runtrelated transcription factor 2. We also show that EMP1 is not expressed in the ossification center of vertebrae but is highly expressed in the nucleus pulposus and growth plate, where chondrocytes are immature and endochondral ossification has not occurred. These results suggest that EMP1 inhibits human spinal chondrocyte differentiation.


πŸ“œ SIMILAR VOLUMES


Autologous protein solution inhibits MMP
✍ Jennifer Woodell-May; Andrea Matuska; Megan Oyster; Zachary Welch; Krista O'Shau πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 353 KB

## Abstract Catabolic inflammatory cytokines are prevalent in osteoarthritis (OA). The purpose of this study was to evaluate an autologous protein solution (APS) as a potential chondroprotective agent for OA therapy. APS was prepared from platelet‐rich plasma (PRP). The APS solution contained both